Hugh Perry is Professor of Experimental Neuropathology at the University of Southampton. His research is in the field of interactions between the immune system and nervous system, and in particular how systemic infection and inflammation play a role in driving the progression of neurodegenerative disease. He has published more than 300 peer-reviewed papers. He has been on research advisory and funding panels for different agencies and chaired the Cellular and Molecular Neuroscience panel of the Wellcome Trust 2004-2007. He has consulted for biotechnology and pharmaceutical companies in the area of neuroinflammation and neurodegenerative disease. He is a Fellow of the Academy of Medical Sciences (2005), was a member of the Nuffield Council on Bioethics (2006-2012), in receipt of a Royal Society Wolfson Research Merit Award (2011) and a Fellow of the Brazilian Academy of Science (2014). He is Chair of the MRC (UK) Neurosciences and Mental Health Board (2012- ) and a member of MRC Strategy Board.